RNU6-1150P

Across TCGA pan-cancer cohorts, RNU6-1150P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-1150P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RNU6-1150P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1150P expression acts as an unfavorable survival marker, although some lineages such as PAAD and MESO show a favorable association.

UCS, KIRC, and PAAD are the cancer types where RNU6-1150P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	All	0.090	0.532	<.001	54	view →
KIRC	DFS	Tertile	III,IV	0.426	0.774	.002	48	view →
PAAD	DFS	Tertile	II,III,IV	0.643	0.255	.011	42	view →
LIHC	DFS	Tertile	II,III,IV	0.060	0.417	<.001	36	view →
MESO	OS	Quartile	All	0.882	0.323	.011	32	view →
CESC	DFS	Tertile	All	0.183	0.561	.021	30	view →
SARC	OS	Tertile	All	0.291	0.753	<.001	27	view →
KICH	DFS	Tertile	All	0.335	0.887	.004	18	view →
TGCT	DFS	Tertile	III,IV	0.017	0.923	.021	18	view →
PRAD	OS	Tertile	All	0.923	0.992	<.001	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU6-1150P–UCS (DFS)

Open the UCS breakdown →